|
WO2015164330A1
(en)
|
2014-04-21 |
2015-10-29 |
Millennium Pharmaceuticals, Inc. |
Anti-psyk antibody molecules and use of same for syk-targeted therapy
|
|
MX2010011463A
(es)
|
2008-04-16 |
2011-06-03 |
Portola Pharm Inc |
2,6-diamino-pirimidin-5-il-carboxamidas como inhibidores de syk o jak quinasas.
|
|
US8138339B2
(en)
|
2008-04-16 |
2012-03-20 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
|
US11351168B1
(en)
|
2008-06-27 |
2022-06-07 |
Celgene Car Llc |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
TWI546290B
(zh)
|
2008-06-27 |
2016-08-21 |
賽基艾維洛米斯研究股份有限公司 |
雜芳基化合物及其用途
|
|
US8338439B2
(en)
*
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
AU2010219097A1
(en)
*
|
2009-01-13 |
2011-08-04 |
Glaxo Group Limited |
Pyrimidinecarboxamide derivatives as inhibitors of SYK kinase
|
|
KR101705158B1
(ko)
|
2009-05-05 |
2017-02-09 |
다나-파버 캔서 인스티튜트 인크. |
Ｅｇｆｒ 억제제 및 질환 치료방법
|
|
SI2428508T1
(sl)
|
2009-05-08 |
2016-04-29 |
Astellas Pharma Inc. |
Diamino heterociklična karboksamidna spojina
|
|
US8410126B2
(en)
*
|
2009-05-29 |
2013-04-02 |
Boehringer Ingelheim International Gmbh |
Pyrimidine inhibitors of PKTK2
|
|
SG181857A1
(en)
|
2009-12-23 |
2012-07-30 |
Takeda Pharmaceutical |
Fused heteroaromatic pyrrolidinones as syk inhibitors
|
|
WO2012002577A1
(ja)
|
2010-06-30 |
2012-01-05 |
富士フイルム株式会社 |
新規なニコチンアミド誘導体またはその塩
|
|
CN105566229A
(zh)
|
2010-08-10 |
2016-05-11 |
西建阿维拉米斯研究公司 |
Btk抑制剂的苯磺酸盐及其用途和制备方法
|
|
AU2011295441B2
(en)
|
2010-08-27 |
2015-04-09 |
Merck Patent Gmbh |
Furopyridine derivatives
|
|
WO2012025186A1
(en)
|
2010-08-27 |
2012-03-01 |
Merck Patent Gmbh |
Triazolopyrazine derivatives
|
|
JP2014005206A
(ja)
*
|
2010-10-22 |
2014-01-16 |
Astellas Pharma Inc |
アリールアミノヘテロ環カルボキサミド化合物
|
|
US20130317029A1
(en)
*
|
2010-11-01 |
2013-11-28 |
Portola Pharmaceuticals, Inc. |
Oxypyrimidines as syk modulators
|
|
EP2635556B1
(en)
*
|
2010-11-01 |
2017-06-21 |
Portola Pharmaceuticals, Inc. |
Benzamides and nicotinamides as syk modulators
|
|
EP2635285B1
(en)
|
2010-11-01 |
2017-05-03 |
Celgene Avilomics Research, Inc. |
Heteroaryl compounds and uses thereof
|
|
MX382354B
(es)
|
2010-11-01 |
2025-03-13 |
Celgene Car Llc |
Compuestos heterocíclicos y usos de los mismos.
|
|
EP2489663A1
(en)
|
2011-02-16 |
2012-08-22 |
Almirall, S.A. |
Compounds as syk kinase inhibitors
|
|
SMT202400031T1
(it)
|
2011-04-22 |
2024-03-13 |
Signal Pharm Llc |
Diamminocarbossammide e diamminocarbonitrile pirimidine sostituite, loro composizioni e metodi di trattamento con esse
|
|
AU2016244228B2
(en)
*
|
2011-04-22 |
2019-02-21 |
Signal Pharmaceuticals, Llc |
Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
|
|
MX2013013090A
(es)
|
2011-05-10 |
2013-12-16 |
Merck Sharp & Dohme |
Aminopirimidinas como inhibidores de tirosina cinaza del bazo.
|
|
EP2707357B1
(en)
|
2011-05-10 |
2017-01-18 |
Merck Sharp & Dohme Corp. |
Pyridyl aminopyridines as syk inhibitors
|
|
US9145391B2
(en)
|
2011-05-10 |
2015-09-29 |
Merck Sharp & Dohme Corp. |
Bipyridylaminopyridines as Syk inhibitors
|
|
JP6026525B2
(ja)
|
2011-06-22 |
2016-11-16 |
武田薬品工業株式会社 |
置換６−アザ−イソインドリン−１−オン誘導体
|
|
EP2763976B1
(en)
*
|
2011-10-05 |
2016-05-18 |
Merck Sharp & Dohme Corp. |
2-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors
|
|
WO2013052393A1
(en)
|
2011-10-05 |
2013-04-11 |
Merck Sharp & Dohme Corp. |
3-PYRIDYL CARBOXAMIDE-CONTAINING SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
|
WO2013052391A1
(en)
|
2011-10-05 |
2013-04-11 |
Merck Sharp & Dohme Corp. |
PHENYL CARBOXAMIDE-CONTAINING SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
|
AR088570A1
(es)
|
2011-10-28 |
2014-06-18 |
Celgene Avilomics Res Inc |
Metodos para tratar una enfermedad o trastorno relacionado con la tirosina quinasa de bruton
|
|
WO2013066729A1
(en)
*
|
2011-10-31 |
2013-05-10 |
Merck Sharp & Dohme Corp. |
Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
|
|
CA3094793A1
(en)
|
2011-11-23 |
2013-05-30 |
Portola Pharmaceuticals, Inc. |
Pyrazine kinase inhibitors
|
|
CA2856306A1
(en)
*
|
2011-11-23 |
2013-05-30 |
Portola Pharmaceuticals, Inc. |
Selective kinase inhibitors
|
|
DK2799431T3
(en)
|
2011-12-28 |
2018-03-26 |
Fujifilm Corp |
Hitherto unknown nicotinamide derivatives or salts thereof
|
|
WO2013104573A1
(en)
*
|
2012-01-10 |
2013-07-18 |
F. Hoffmann-La Roche Ag |
Pyridazine amide compounds and their use as syk inhibitors
|
|
PL2805940T3
(pl)
*
|
2012-01-17 |
2017-06-30 |
Astellas Pharma Inc. |
Związek pirazynokarboksyamidowy
|
|
CA2863723C
(en)
|
2012-02-21 |
2020-09-22 |
Carl Deutsch |
8-substituted 2-amino-[1,2,4]triazolo[1,5-a]pyrazines as syk tryrosine kinase inhibitors and gcn2 serin kinase inhibitors
|
|
AU2013224420B2
(en)
|
2012-02-21 |
2016-12-15 |
Merck Patent Gmbh |
Furopyridine derivatives
|
|
UY34807A
(es)
*
|
2012-05-16 |
2013-12-31 |
Novartis Ag |
Derivados monocíclicos de heteroarilcicloalquil- diamina
|
|
EP2863914B1
(en)
|
2012-06-20 |
2018-10-03 |
Merck Sharp & Dohme Corp. |
Pyrazolyl derivatives as syk inhibitors
|
|
US9487504B2
(en)
|
2012-06-20 |
2016-11-08 |
Merck Sharp & Dohme Corp. |
Imidazolyl analogs as syk inhibitors
|
|
EP2863915B1
(en)
|
2012-06-22 |
2017-12-06 |
Merck Sharp & Dohme Corp. |
SUBSTITUTED DIAZINE AND TRIAZINE SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
|
US9040530B2
(en)
*
|
2012-06-22 |
2015-05-26 |
Portola Pharmaceuticals, Inc. |
1,2,4-triazine-6-carboxamide kinase inhibitors
|
|
EP2863916B1
(en)
|
2012-06-22 |
2018-07-18 |
Merck Sharp & Dohme Corp. |
Substituted pyridine spleen tyrosine kinase (syk) inhibitors
|
|
US20140113931A1
(en)
*
|
2012-06-22 |
2014-04-24 |
Portola Pharmaceuticals, Inc. |
Substituted picolinamide kinase inhibitors
|
|
ES2618004T3
(es)
|
2012-08-07 |
2017-06-20 |
Merck Patent Gmbh |
Derivados de piridopirimidina como inhibidores de proteínas quinasas
|
|
EP2884982B1
(en)
|
2012-08-20 |
2017-09-20 |
Merck Sharp & Dohme Corp. |
SUBSTITUTED PHENYL SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
|
EP2897950A1
(en)
|
2012-09-18 |
2015-07-29 |
Ziarco Pharma Ltd |
2-(2-aminocyclohexyl)amino-pyrimidine-5-carboxamides as spleen tyrosine kinasei(syk) inhibitors
|
|
EP2900665B1
(en)
|
2012-09-28 |
2018-01-03 |
Merck Sharp & Dohme Corp. |
Triazolyl derivatives as syk inhibitors
|
|
CR20190436A
(es)
|
2012-10-02 |
2019-10-29 |
Bayer Cropscience Ag |
COMPUESTOS HETEROCICLICOS COMO PLAGUICIDAS (Divisional 2015-0182)
|
|
HK1211024A1
(en)
|
2012-10-19 |
2016-05-13 |
霍夫曼-拉罗奇有限公司 |
Inhibitors of syk
|
|
SG11201503395TA
(en)
*
|
2012-11-08 |
2015-05-28 |
Bristol Myers Squibb Co |
ALKYL AMIDE-SUBSTITUTED PYRIMIDINE COMPOUNDS USEFUL IN THE MODULATION OF IL-12, IL-23 AND/OR IFNα
|
|
WO2014093191A1
(en)
|
2012-12-12 |
2014-06-19 |
Merck Sharp & Dohme Corp. |
AMINO-PYRIMIDINE-CONTAINING SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
|
US9126950B2
(en)
|
2012-12-21 |
2015-09-08 |
Celgene Avilomics Research, Inc. |
Heteroaryl compounds and uses thereof
|
|
EP2934525B1
(en)
|
2012-12-21 |
2019-05-08 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitors
|
|
AU2014214846A1
(en)
|
2013-02-08 |
2015-07-23 |
Celgene Avilomics Research, Inc. |
ERK inhibitors and uses thereof
|
|
US20160009694A1
(en)
*
|
2013-03-15 |
2016-01-14 |
Portola Pharmaceuticals, Inc. |
Cyclohexanediamine compounds and methods for their preparation
|
|
JP2016113366A
(ja)
*
|
2013-03-29 |
2016-06-23 |
大鵬薬品工業株式会社 |
アセトアミド基を有する１，２，４−トリアジン−６−カルボキサミド誘導体
|
|
EP2988744A4
(en)
|
2013-04-26 |
2016-11-02 |
Merck Sharp & Dohme |
THIAZOLSUBSTITUTED AMINOHETEROARYLE AS MILZTYROSINKINASE INHIBITOR
|
|
EP2988749B1
(en)
|
2013-04-26 |
2019-08-14 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitors
|
|
KR101665301B1
(ko)
|
2013-08-07 |
2016-10-11 |
카딜라 핼쓰캐어 리미티드 |
야누스 키나제의 억제제로서 n-시아노메틸아미드
|
|
US9492471B2
(en)
|
2013-08-27 |
2016-11-15 |
Celgene Avilomics Research, Inc. |
Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase
|
|
WO2015039613A1
(zh)
*
|
2013-09-18 |
2015-03-26 |
北京韩美药品有限公司 |
抑制btk和/或jak3激酶活性的化合物
|
|
AU2014360446A1
(en)
|
2013-12-05 |
2016-06-09 |
Pharmacyclics, Llc |
Inhibitors of Bruton's tyrosine kinase
|
|
US9822107B2
(en)
|
2013-12-20 |
2017-11-21 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
|
EP3083560B1
(en)
|
2013-12-20 |
2021-10-27 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
|
US9783531B2
(en)
|
2013-12-20 |
2017-10-10 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
|
NZ715903A
(en)
|
2014-01-30 |
2017-06-30 |
Signal Pharm Llc |
Solid forms of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use
|
|
WO2015138273A1
(en)
|
2014-03-13 |
2015-09-17 |
Merck Sharp & Dohme Corp. |
2-pyrazine carboxamides as spleen tyrosine kinase inhibitors
|
|
WO2016020403A1
(en)
*
|
2014-08-04 |
2016-02-11 |
Sandoz Ag |
Preparation of a benzoic acid derivative and its use for the preparation of suvorexant
|
|
US10005760B2
(en)
|
2014-08-13 |
2018-06-26 |
Celgene Car Llc |
Forms and compositions of an ERK inhibitor
|
|
EP3233808B1
(en)
|
2014-12-16 |
2021-07-14 |
Signal Pharmaceuticals, LLC |
Medical uses comprising methods for measurement of inhibition of c-jun n-terminal kinase in skin
|
|
BR112017012795A2
(pt)
|
2014-12-16 |
2018-01-02 |
Signal Pharmaceuticals, Llc |
Formulações de 2-(terc-butilamino)-4-((1r,3r,4r)-3- hidroxi-4-metilciclo-hexilamino)-pirimidina-5- carboxamida
|
|
WO2016123291A1
(en)
|
2015-01-29 |
2016-08-04 |
Signal Pharmaceuticals, Llc |
Isotopologues of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide
|
|
CA3208587A1
(en)
|
2015-07-24 |
2017-02-02 |
Celgene Corporation |
Methods of synthesis of (1r,2r,5r)-5-amino-2-methylcyclohexanol hydrochloride and intermediates useful therein
|
|
JP6833816B2
(ja)
*
|
2015-08-12 |
2021-02-24 |
ポートラ ファーマシューティカルズ， インコーポレイテッド |
骨髄腫を治療するためのセルデュラチニブ（ｃｅｒｄｕｌａｔｉｎｉｂ）
|
|
HUE064145T2
(hu)
*
|
2016-04-15 |
2024-03-28 |
Epizyme Inc |
Amin-szubsztituált aril- vagy heteroaril vegyületek, mint EHMT1 és EHMT2 inhibitorok
|
|
JP6999688B2
(ja)
*
|
2016-12-13 |
2022-02-10 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｂｃｌ６阻害剤としての新規の６－アミノキノリノン化合物および誘導体
|
|
CN110621316B
(zh)
|
2017-04-21 |
2024-01-26 |
Epizyme股份有限公司 |
用ehmt2抑制剂进行的组合疗法
|
|
CN109384774B
(zh)
*
|
2017-08-11 |
2023-02-17 |
中国科学院上海药物研究所 |
一类多取代的吡嗪/三嗪酰胺类化合物及其制备方法和应用
|
|
CA3079292A1
(en)
|
2017-10-19 |
2019-04-25 |
Bayer Animal Health Gmbh |
Use of fused heteroaromatic pyrrolidones for treatment and prevention of diseases in animals
|
|
US10683297B2
(en)
*
|
2017-11-19 |
2020-06-16 |
Calitor Sciences, Llc |
Substituted heteroaryl compounds and methods of use
|
|
CN112243375A
(zh)
*
|
2018-03-09 |
2021-01-19 |
博尔托拉制药公司 |
选择性syk抑制剂的使用方法及药物组合物
|
|
CR20200553A
(es)
|
2018-04-18 |
2021-04-08 |
Constellation Pharmaceuticals Inc |
Moduladores de enzimas modificadoras de metilo, composiciones y usos de estos
|
|
CN120097995A
(zh)
|
2018-05-21 |
2025-06-06 |
星座制药公司 |
甲基修饰酶的调节剂、其组合物和用途
|
|
AU2019364336B2
(en)
|
2018-10-22 |
2023-11-16 |
Alumis Inc. |
TYK2 inhibitors and uses thereof
|
|
US20220143049A1
(en)
|
2019-03-21 |
2022-05-12 |
Onxeo |
A dbait molecule in combination with kinase inhibitor for the treatment of cancer
|
|
WO2021016414A1
(en)
|
2019-07-24 |
2021-01-28 |
Constellation Pharmaceuticals, Inc. |
Crystalline forms of 7-chloro-2-(4-(3-methoxyazetidin-1-yl)cyclohexyl)-2,4-dimethyl-n-((6-methyl-4-(methylthio)-2-oxo-1,2-dihydropyridin-3-yl)methyl)benzo[d][1,3]dioxole-5-carboxamide
|
|
EP4054579A1
(en)
|
2019-11-08 |
2022-09-14 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Methods for the treatment of cancers that have acquired resistance to kinase inhibitors
|
|
WO2021148581A1
(en)
|
2020-01-22 |
2021-07-29 |
Onxeo |
Novel dbait molecule and its use
|
|
WO2021155185A1
(en)
*
|
2020-01-30 |
2021-08-05 |
Sumitomo Dainippon Pharma Oncology, Inc. |
Aminopyrimidinylaminobenzonitrile derivatives as nek2 inhibitors
|
|
WO2022078305A1
(zh)
*
|
2020-10-12 |
2022-04-21 |
四川海思科制药有限公司 |
一种杂环衍生物及其在医药上的应用
|
|
EP4240362A4
(en)
*
|
2020-11-09 |
2024-10-23 |
Merck Sharp & Dohme LLC |
Diaminopyrimidine carboxamide inhibitors of hpk1
|
|
US12600721B2
(en)
|
2021-02-19 |
2026-04-14 |
Sudo Biosciences Limited |
TYK2 inhibitors and uses thereof
|
|
CA3207819A1
(en)
|
2021-02-19 |
2022-08-25 |
Anjali Pandey |
Tyk2 inhibitors and uses thereof
|
|
CN117120440A
(zh)
*
|
2021-02-19 |
2023-11-24 |
苏多生物科学有限公司 |
Tyk2抑制剂及其用途
|
|
IL305165A
(en)
|
2021-02-19 |
2023-10-01 |
Sudo Biosciences Ltd |
Tyk2 inhibitors and uses thereof
|
|
WO2022175745A1
(en)
*
|
2021-02-19 |
2022-08-25 |
Sudo Biosciences Limited |
Tyk2 inhibitors and uses thereof
|
|
CN117242072A
(zh)
*
|
2021-02-19 |
2023-12-15 |
苏多生物科学有限公司 |
Tyk2抑制剂及其用途
|
|
CN120617271A
(zh)
*
|
2021-03-09 |
2025-09-12 |
石药集团中奇制药技术（石家庄）有限公司 |
一种含有三环杂芳基的化合物的用途
|
|
CN115197196B
(zh)
*
|
2021-04-06 |
2024-06-18 |
扬子江药业集团有限公司 |
Tyk2抑制剂及其用途
|
|
WO2023108536A1
(en)
*
|
2021-12-16 |
2023-06-22 |
Lynk Pharmaceuticals Co. Ltd. |
Tyk2 inhibitors and compositions and methods thereof
|
|
EP4448514A4
(en)
*
|
2021-12-16 |
2025-10-29 |
Lynk Pharmaceuticals Co Ltd |
TYK2 INHIBITORS AND ASSOCIATED COMPOSITIONS AND PROCESSES
|
|
CN116120282B
(zh)
*
|
2022-08-04 |
2024-02-20 |
苏州系统医学研究所 |
具有ev71和/或cva16病毒抑制活性的化合物及其应用
|
|
CN116925053A
(zh)
*
|
2023-07-26 |
2023-10-24 |
成都赜灵生物医药科技有限公司 |
甲磺酸普依司他中间体的杂质去除工艺
|
|
CN118440052B
(zh)
*
|
2024-07-05 |
2024-10-11 |
四川大学 |
一种化合物及其在制备tyk2激酶抑制剂中的用途
|
|
CN120665299B
(zh)
*
|
2025-05-23 |
2026-03-27 |
广东药科大学 |
一种金属有机框架材料及其制备方法和应用
|